Target- |
Mechanism- |
Active Org.- |
|
Active Indication- |
|
Drug Highest PhaseDiscontinued |
First Approval Ctry. / Loc.- |
First Approval Date- |
Phase I, Pilot Study in Healthy Volunteers, to Assess the Safety and Pharmacokinetics of PCO-02, Which Active Ingredient is BPC-157, a Penta-deca-peptide From Gastric Source.
Phase I clinical trial in healthy volunteers to study safety and pharmacokinetics of BPC-157, a pentadecapeptide from gastric source.
100 Clinical Results associated with PHARMACOTHERAPIA D.O.O.
0 Patents (Medical) associated with PHARMACOTHERAPIA D.O.O.
100 Deals associated with PHARMACOTHERAPIA D.O.O.
100 Translational Medicine associated with PHARMACOTHERAPIA D.O.O.